Buy or sell RefleXion Medical stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

RefleXion Medical Stock

The first biologically-guided radiation therapy for cancer.

Founded

2009

Notable Investors

The Rise Fund

Headquarters

Hayward CA, US

Total Funding

$291M

About RefleXion Medical Stock

RefleXion Medical is a privately held medical device company developing the first biology-guided radiation therapy system for cancer treatment. By leveraging Positron Emission Tomography (PET) in a novel way, RefleXion's patented technology will allow tumors to continuously signal their location during treatment and potentially revolutionize the practice of radiation oncology. Early validation of RefleXion's technology was funded by the National Cancer Institute. RefleXion is backed by premier investors; Sofinnova Partners, KCK, Pfizer, Venrock and Johnson & Johnson Innovation.

Investors

Sofinnova Partners

RefleXion Medical

Funding History

April 2014$11.7M
April 2016$52.1M
March 2018$103M
April 2020$125M

Management

Founder and CTO

Sam Mazin

President & CEO

Todd Powell

Principal UX Engineer

Michael Owens

Vice President of Engineering

David Larkin

Senior Director - Product

Cal Huntzinger

VP, Regulatory/Clinical/QA

Kathy O’Shaughnessy

Founder and VP of Business Development

Akshay Nanduri

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from RefleXion Medical or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 90K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo